Active Agent Ranking From Multi-Marker OMICS for Cell Response

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Ribonucleic acid (RNA) analysis and other OMICS analysis produce charts that are difficult to interpret due to transcriptomic heterogeneity and variability, requiring expert-level understanding and often leading to biased interpretations.

Innovation Solution

Systems and methods for scoring and ranking active agents applied to cell samples using multi-marker OMICS analysis, including gene expression models, to determine adjusted formulas based on these rankings, reducing interpretation complexity and bias.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If expert users interpret OMICS analysis outputs manually, then interpretation accuracy may be maintained, but interpretation time and complexity increase significantly

Engineering Contradiction:
Improveinterpretation accuracyVSAvoidinterpretation time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The system enables self-service interpretation by automatically generating ranked lists of active agents based on OMICS data, eliminating the need for expert manual analysis. The automated ranking system processes transcriptomic data and delivers actionable results without requiring user expertise in omics analysis.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces manual mechanical interpretation processes with automated computational algorithms. The system uses computer-generated rankings and visualizations instead of human expert analysis, substituting the mechanical process of manual data review with automated digital processing.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If manual interpretation of OMICS charts is performed, then detailed analysis can be conducted, but user bias and subjectivity increase

Engineering Contradiction:
Improveanalysis detailVSAvoidinterpretation objectivity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The automated ranking system performs self-service analysis without human intervention, eliminating subjective bias. The system objectively processes OMICS data through standardized algorithms, ensuring consistent and reproducible results that are not influenced by user preferences or experiences.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system changes the parameter of analysis from subjective human judgment to objective computational metrics. By transforming qualitative expert interpretation into quantitative automated ranking, the system maintains detailed analysis while ensuring reliability through consistent, bias-free parameter evaluation.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If complex OMICS analysis is performed, then comprehensive data can be obtained, but ease of operation decreases

Engineering Contradiction:
Improvedata comprehensivenessVSAvoiduser accessibility
Core Design Contradiction:
Quantity of substanceVSEase of operation

Solution Approach 1:

The system makes comprehensive OMICS analysis self-service by automatically processing complex data and presenting simplified ranked results. Users can access comprehensive active agent efficacy data without needing to understand or manually process the underlying complex transcriptomic data, maintaining both comprehensiveness and ease of operation.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS20260066045A1Systems and methods for ranking active agents
Publication Date: 2026.03.05 LOREAL SA
  • US20260066045A1 patent drawing
  • US20260066045A1 patent drawing
  • US20260066045A1 patent drawing

AI summary

Systems, apparatuses, methods, and computer program products are disclosed for ranking a plurality of active agents applied to cells of interest. In an embodiment, the method may include a multi-marker genetic or OMICs analysis of a plurality of portions of treated cells, each of the portions of treated cells being treated with one or more of a plurality of active agents. The method may include determining a rank for each of the plurality of active agents for one or more selected characteristics based on application of the multi-marker OMICS analysis to an expression model for the one or more selected characteristics. The method may include determining one or more adjusted formula of a mixture including one or more of the plurality of active agents based on the rank.